ERYTHEMATOTELANGIECTATIC ROSACEA

Clinical trials for ERYTHEMATOTELANGIECTATIC ROSACEA explained in plain language.

Never miss a new study

Get alerted when new ERYTHEMATOTELANGIECTATIC ROSACEA trials appear

Sign up with your email to follow new studies for ERYTHEMATOTELANGIECTATIC ROSACEA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New light and drug combo targets rosacea redness

Disease control Not yet recruiting

This study aims to see if a combination treatment is effective and safe for controlling a common skin condition called rosacea. It will test a specific light therapy and two medications (tofacitinib and doxycycline) in 186 Chinese adults with mild to moderate facial redness and v…

Matched conditions: ERYTHEMATOTELANGIECTATIC ROSACEA

Phase: NA • Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine • Aim: Disease control

Last updated Mar 23, 2026 15:15 UTC

ERYTHEMATOTELANGIECTATIC ROSACEA

Get alerted when new ERYTHEMATOTELANGIECTATIC ROSACEA trials appear

New light and drug combo targets rosacea redness